Drug Trial Radar · NCT00412971
A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer
Last checked: Nov 20, 2026Latest source record: Oct 11, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
233
Actual
Start
Apr 2005
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- PhotocureIndustry
- Sponsor type
- Industry
- First posted
- Dec 19, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of the study is to compare the 1-year recurrence rate of Hexvix assisted Transuretheral Resection of the Bladder (TURB) to standard white light TURB in patients with suspicion of non-invasive bladder cancer. The hypothesis is to test whether the 1-year recurrence rate is different with Hexvix assisted TURB compared to standard white light TURB.
Conditions
- Bladder Cancer
Interventions
HexvixDrug
Single installation, TURB
Standard white light cystoscopyOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Patients With Histologically Confirmed Recurrence Within One 1 Year.Time frame: 1 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Frederiksberg Hospital
Frederiksberg, Denmark
Odense University Hospital
Odense, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.